Integrated Diagnostics Holdings plc (IDHC.L) Comparison with companies in other sectors?

Integrated Diagnostics Holdings plc has a share price of 581.33M. You can analyze Integrated Diagnostics Holdings plc (IDHC.L) competitors across different market sectors through stock heatmaps.

What are IDHC.L's NET and operating margins?

Integrated Diagnostics Holdings plc (IDHC.L) operating margin is around 0.18, and net profit margin is approximately 0.18 as of the latest reports.

In what way does IDHC.L's earnings per share (EPS) trend reflect its financial momentum?

Integrated Diagnostics Holdings plc (IDHC.L) EPS is 0.04 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Integrated Diagnostics Holdings plc is 8.95, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Integrated Diagnostics Holdings plc?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Integrated Diagnostics Holdings plc like P/E which is 16.33, P/B which is 3.75, and PEG which is 0.04. Compare them with sector averages to evaluate if the stock is priced fairly.

Integrated Diagnostics Holdings plc

IDHC.L•LSE

Healthcare

Medical - Diagnostics & Research

£0.36

£0.003(0.85%)

Integrated Diagnostics Holdings plc (IDHC.L) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.04

P/E Ratio

8.95

ROE

0.24%

Net Margin

0.18%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$208.11M

Shares OutstandingTotal number of shares issued

$581.33M

Book Value/ShareNet worth per share

$5.92

Revenue/ShareAnnual revenue per share

$5.94

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.04

Net MarginNet income as percentage of revenue

17.93%

Operating MarginOperating income as percentage of revenue

18.18%

ROEReturn on shareholders' equity

23.56%

ROAReturn on total assets

9.45%

ROCEReturn on capital employed

12.81%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.74

Cash/ShareCash and equivalents per share

$2.16

FCF YieldFree cash flow as percentage of market cap

4.41%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for IDHC.LFinancial Ratios Analysis details for IDHC.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for IDHC.LSector Benchmarking details for IDHC.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Integrated Diagnostics Holdings plc Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Integrated Diagnostics Holdings plc. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Integrated Diagnostics Holdings plc's unique business strengths and challenges.

Key Financial Metrics for Integrated Diagnostics Holdings plc

For Integrated Diagnostics Holdings plc, essential financial indicators include EPS 0.04, PE 8.95, and ROE 0.24. These key ratios reveal insights into Integrated Diagnostics Holdings plc's profitability, valuation, and operational health. Understanding these metrics enables you to compare Integrated Diagnostics Holdings plc with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Integrated Diagnostics Holdings plc

Metrics like Net Margin 17.93% and ROA 9.45% shed light on how well Integrated Diagnostics Holdings plc is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Integrated Diagnostics Holdings plc can sustain its operations and continue growing in the future.

Valuation and Market Position of Integrated Diagnostics Holdings plc

Using ratios such as P/B Ratio 3.75 and PEG Ratio 0.04, investors can assess whether Integrated Diagnostics Holdings plc is appropriately valued based on its financials and growth potential. These figures, combined with Integrated Diagnostics Holdings plc's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Integrated Diagnostics Holdings plc

Financial health indicators, such as Debt/Equity Ratio 0.46 and Cash Flow $0.74, provide a snapshot of Integrated Diagnostics Holdings plc's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Integrated Diagnostics Holdings plc, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Integrated Diagnostics Holdings plc

Investing in Integrated Diagnostics Holdings plc based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Integrated Diagnostics Holdings plc focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;